Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia - PubMed
. 2007 Nov;50(11):2374-83.
doi: 10.1007/s00125-007-0791-0. Epub 2007 Sep 6.
Affiliations
- PMID: 17823788
- DOI: 10.1007/s00125-007-0791-0
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
P D Cani et al. Diabetologia. 2007 Nov.
Abstract
Aims/hypothesis: Recent evidence suggests that a particular gut microbial community may favour occurrence of the metabolic diseases. Recently, we reported that high-fat (HF) feeding was associated with higher endotoxaemia and lower Bifidobacterium species (spp.) caecal content in mice. We therefore tested whether restoration of the quantity of caecal Bifidobacterium spp. could modulate metabolic endotoxaemia, the inflammatory tone and the development of diabetes.
Methods: Since bifidobacteria have been reported to reduce intestinal endotoxin levels and improve mucosal barrier function, we specifically increased the gut bifidobacterial content of HF-diet-fed mice through the use of a prebiotic (oligofructose [OFS]).
Results: Compared with normal chow-fed control mice, HF feeding significantly reduced intestinal Gram-negative and Gram-positive bacteria including levels of bifidobacteria, a dominant member of the intestinal microbiota, which is seen as physiologically positive. As expected, HF-OFS-fed mice had totally restored quantities of bifidobacteria. HF-feeding significantly increased endotoxaemia, which was normalised to control levels in HF-OFS-treated mice. Multiple-correlation analyses showed that endotoxaemia significantly and negatively correlated with Bifidobacterium spp., but no relationship was seen between endotoxaemia and any other bacterial group. Finally, in HF-OFS-treated-mice, Bifidobacterium spp. significantly and positively correlated with improved glucose tolerance, glucose-induced insulin secretion and normalised inflammatory tone (decreased endotoxaemia, plasma and adipose tissue proinflammatory cytokines).
Conclusions/interpretation: Together, these findings suggest that the gut microbiota contribute towards the pathophysiological regulation of endotoxaemia and set the tone of inflammation for occurrence of diabetes and/or obesity. Thus, it would be useful to develop specific strategies for modifying gut microbiota in favour of bifidobacteria to prevent the deleterious effect of HF-diet-induced metabolic diseases.
Comment in
-
The gut-liver-axis: endotoxemia, inflammation, insulin resistance and NASH.
Siebler J, Galle PR, Weber MM. Siebler J, et al. J Hepatol. 2008 Jun;48(6):1032-4. doi: 10.1016/j.jhep.2008.03.007. Epub 2008 Apr 3. J Hepatol. 2008. PMID: 18468548 No abstract available.
Similar articles
-
Chen JJ, Wang R, Li XF, Wang RL. Chen JJ, et al. Exp Biol Med (Maywood). 2011 Jul;236(7):823-31. doi: 10.1258/ebm.2011.010399. Epub 2011 Jun 17. Exp Biol Med (Maywood). 2011. PMID: 21685239
-
Neyrinck AM, Possemiers S, Druart C, Van de Wiele T, De Backer F, Cani PD, Larondelle Y, Delzenne NM. Neyrinck AM, et al. PLoS One. 2011;6(6):e20944. doi: 10.1371/journal.pone.0020944. Epub 2011 Jun 9. PLoS One. 2011. PMID: 21695273 Free PMC article.
-
Woting A, Pfeiffer N, Hanske L, Loh G, Klaus S, Blaut M. Woting A, et al. Mol Nutr Food Res. 2015 Nov;59(11):2267-78. doi: 10.1002/mnfr.201500249. Epub 2015 Aug 26. Mol Nutr Food Res. 2015. PMID: 26202344 Free PMC article.
-
Cani PD, Delzenne NM, Amar J, Burcelin R. Cani PD, et al. Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Epub 2008 Jan 30. Pathol Biol (Paris). 2008. PMID: 18178333 Review.
-
Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Geurts L, et al. Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065. Benef Microbes. 2014. PMID: 23886976 Review.
Cited by
-
Zhang L, Zhang Y, Liu J, Li Y, Quan J. Zhang L, et al. Diabetes Metab Syndr Obes. 2022 Oct 17;15:3143-3152. doi: 10.2147/DMSO.S377776. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36262806 Free PMC article.
-
Nutritional Strategies against Diabetic Nephropathy: Insights from Animal Studies and Human Trials.
Zhou J, Franceschini N, Townley-Tilson WHD, Maeda-Smithies N. Zhou J, et al. Nutrients. 2024 Jun 18;16(12):1918. doi: 10.3390/nu16121918. Nutrients. 2024. PMID: 38931271 Free PMC article. Review.
-
Zhou C, Bisseling TM, van der Post RS, Boleij A. Zhou C, et al. Comput Struct Biotechnol J. 2023 Nov 30;23:186-198. doi: 10.1016/j.csbj.2023.11.053. eCollection 2024 Dec. Comput Struct Biotechnol J. 2023. PMID: 38075398 Free PMC article. Review.
-
Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications.
Yamashiro K, Kurita N, Urabe T, Hattori N. Yamashiro K, et al. Ann Nutr Metab. 2021;77 Suppl 2(Suppl 2):36-44. doi: 10.1159/000516398. Epub 2021 Jun 9. Ann Nutr Metab. 2021. PMID: 34107468 Free PMC article. Review.
-
Pushpanathan P, Srikanth P, Seshadri KG, Selvarajan S, Pitani RS, Kumar TD, Janarthanan R. Pushpanathan P, et al. Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):523-30. doi: 10.4103/2230-8210.183474. Indian J Endocrinol Metab. 2016. PMID: 27366720 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous